 Investors dont seem impressed with AstraZenecas LON: AZN latest deal, which is also the biggest deal in the companys history. Fundamental analysis: Hefty price paid The British-Swedish pharma giant agreed to pay 39 billion to buy Alexion Pharmaceuticals in a major push to increase its market share in the areas of immunology and rare-disease drugs. 